LMNTD2
Lamin tail domain-containing protein 2
Also known as: C11orf35, LMTD2_HUMAN, MGC35138
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IXW0
- Gene
- LMNTD2
- Ensembl
- ENSG00000185522
- Chromosome
- 11
- Canonical length
- 634 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytoplasmic bodies
OverviewNCBI Gene
Predicted to be a structural constituent of chromatin. Predicted to act upstream of or within positive regulation of mRNA splicing, via spliceosome. Predicted to be active in lamin filament. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
634 residues, UniProt reviewed canonical sequence.
>Q8IXW0|LMNTD2
1 MRWLRPAGRR REQESVSGHL GPPAGAPAAP ETPTCLPDTT PHPAPVVCSA DPQLALESLD
61 PRTLRLLWRQ RELEIQALRW AIQNGEDARL CHILEEVAGL PPKRSSHSQE KLLQNQVQKL
121 IQELKEQKER AQWEKEHLEE RLLQTTRTLQ EMEAELQNLQ KSCLLQLARS SWVGRMLRSQ
181 TGSVEVVTAE TLMDPSDLSE NIQAPTGEGF RLEDVDWNSV ARRYPNLFTN MEPSSKQKQP
241 RPWPQLDTGS PESSGKHSER HHKTVEWGSL PCLNTSSSGG ADSDSSSCRP GLPSFVQVIG
301 HPPRDHRASS EQALVQAGSY SRDSEDLQKT HSPRHGEPVL SPQPCTDPDH WSPELLQSPT
361 GLKIVAVSCR EKFVRIFNPS QESTADLSGM VLKQLVRGFP ERLYRFPPGT LLAPRHHVTV
421 WGEATRSAKK PLRASSSREP VPLLSIRGCA TLLLSPKGEV LSEHRIPRRE TPAPRVFADG
481 TDLSIDRFPL PEAGPGADTR KPPRPPRPLR KGRVREPRVS RRRPGTRGLL PPVSSGKLFH
541 AREGPARPEN PEIPAPQHLP AIPGDPTLPS PPAEAGLGLE DCRLQKEHRV RVCRKSVDRS
601 CPLVALSVQN TAESRFGFRF LSCLPVTADT CRGALocalizationUniProt · AlphaFold · HPA
Whether an antibody against LMNTD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 27 nTPM
Expression across tissuesHPA
Tissue
- testis: 27 nTPM
- liver: 24 nTPM
- kidney: 10 nTPM
- thyroid gland: 8.4 nTPM
- pancreas: 8.2 nTPM
- skin: 6.7 nTPM
Single-cell type
- late spermatids: 115 nCPM
- early spermatids: 60 nCPM
- tuft cells: 12 nCPM
- late primary spermatocytes: 9.5 nCPM
- proximal tubule cells: 8.8 nCPM
- renal collecting duct principal cells: 6.1 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 5.8 nTPM
- basal ganglia: 3.5 nTPM
- cerebral cortex: 3.2 nTPM
- pons: 2 nTPM
- medulla oblongata: 1.8 nTPM
- thalamus: 1.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.74
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Lamin tail domain
- Lamin tail domain superfamily
- Lamin Tail Domain
- Lamin Tail Domain-Containing Protein
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LMNTD2 as an antibody target. Whether an autoantibody or antibody against LMNTD2 could matter depends on whether native LMNTD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LMNTD2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LMNTD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...